Bibliotecas PUC-SP - Busca Integrada

Clinical analysis of two kinds of surgical procedures for the treatment of communicating hydrocephalus

Por An-xi ZHENG, Xiao-ming HUANG, Xiao-dong YUAN, Wen-hua TANG, Shi-ping CHEN, Wen CHENG, Yu ZHANG
Publicado no Chinese Journal of Contemporary Neurology and Neurosurgery (2014-10-01)

LncRNA USP2-AS1 Promotes Hepatocellular Carcinoma Growth by Enhancing YBX1-Mediated HIF1α Protein Translation Under Hypoxia

Por Shi-Ping Chen, Gui-Qi Zhu, Xiao-Xia Xing, Xiao-Xia Xing, Jing-Lei Wan, Jia-Liang Cai, Jun-Xian Du, Li-Na Song, Zhi Dai, Zhi Dai, Jian Zhou
Publicado no Frontiers in Oncology (2022-05-01)

Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer

Por Qiu‐Zhong Pan, Jia‐Mei Gu, Jing‐Jing Zhao, Yan Tang, Qi‐Jing Wang, Qian Zhu, Meng‐Jia Song, Yong‐Qiang Li, Jia He, Shi‐Ping Chen, De‐Sheng Weng, Jian‐Chuan Xia
Publicado no Clinical & Translational Immunology (2020-01-01)

Reduced expression of transcription factor AP-2α is associated with gastric adenocarcinoma prognosis.

Por Wei Wang, Lin Lv, Ke Pan, Yu Zhang, Jing-jing Zhao, Ju-gao Chen, Yi-bing Chen, Yong-qiang Li, Qi-jin Wang, Jia He, Shi-ping Chen, Zhi-wei Zhou, Jian-chuan Xia
Publicado no PLoS ONE (2011-01-01)

Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1

Por Jun-Xian Du, Yi-Hong Luo, Si-Jia Zhang, Biao Wang, Cong Chen, Gui-Qi Zhu, Ping Zhu, Cheng-Zhe Cai, Jing-Lei Wan, Jia-Liang Cai, Shi-Ping Chen, Zhi Dai, Wei Zhu
Publicado no Journal of Experimental & Clinical Cancer Research (2021-05-01)

Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.

Por Dan-dan Wang, Yi-bing Chen, Ke Pan, Wei Wang, Shi-ping Chen, Ju-gao Chen, Jing-jing Zhao, Lin Lv, Qiu-zhong Pan, Yong-qiang Li, Qi-jing Wang, Li-Xi Huang, Miao-la Ke, Jia He, Jian-Chuan Xia
Publicado no PLoS ONE (2012-01-01)

A multicenter, randomized clinical trial comparing the three-weekly docetaxel regimen plus prednisone versus mitoxantone plus prednisone for Chinese patients with metastatic castra...

Por Tie Zhou, Shu-xiong Zeng, Ding-wei Ye, Qiang Wei, Xu Zhang, Yi-ran Huang, Zhang-qun Ye, Yong Yang, Wei Zhang, Ye Tian, Fang-jian Zhou, Jin Jie, Shi-ping Chen, Yan Sun, Li-ping Xie, Xing Yao, Yan-qun Na, Ying-hao Sun
Publicado no PLoS ONE (2015-01-01)

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

Por Qiu-Zhong Pan, Jing-Jing Zhao, Chao-Pin Yang, Yu-Qing Zhou, Jun-Zhong Lin, Yan Tang, Jia-Mei Gu, Qi-Jing Wang, Yong-Qiang Li, Jia He, Shi-Ping Chen, Meng-Jia Song, Yue Huang, Jie-Ying Yang, De-Sheng Weng, Jian-Chuan Xia
Publicado no OncoImmunology (2020-01-01)

Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular CarcinomaSummary

Por Gui-Qi Zhu, Yi Wang, Biao Wang, Wei-Ren Liu, Shuang-Shuang Dong, Er-Bao Chen, Jia-Liang Cai, Jing-Lei Wan, Jun-Xian Du, Li-Na Song, Shi-Ping Chen, Lei Yu, Zheng-Jun Zhou, Zheng Wang, Jian Zhou, Ying-Hong Shi, Jia Fan, Zhi Dai
Publicado no Cellular and Molecular Gastroenterology and Hepatology (2022-01-01)

Intratumoral Expression of IL-17 and Its Prognostic Role in Gastric Adenocarcinoma Patients

Por Ju-gao Chen, Jian-chuan Xia, Xiao-ting Liang, Ke Pan, Wei Wang, Lin Lv, Jing-jing Zhao, Qi-jing Wang, Yong-qiang Li, Shi-ping Chen, Jia He, Li-xi Huang, Miao-la Ke, Yi-bing Chen, Hai-qing Ma, Zhen-wu Zeng, Zhi-wei Zhou, Alfred E Chang, Qiao Li
Publicado no International Journal of Biological Sciences (2011-01-01)

Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells

Por Gui-Qi Zhu, Zheng Tang, Tian-Hao Chu, Biao Wang, Shi-Ping Chen, Chen-Yang Tao, Jia-Liang Cai, Rui Yang, Wei-Feng Qu, Yi Wang, Qian-Fu Zhao, Run Huang, Meng-Xin Tian, Yuan Fang, Jun Gao, Xiao-Ling Wu, Jian Zhou, Wei-Ren Liu, Zhi Dai, Ying-Hong Shi, Jia Fan
Publicado no Signal Transduction and Targeted Therapy (2025-01-01)

The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 s...

Por Meng‐Jia Song, Qiu‐Zhong Pan, Ya Ding, Jianxiong Zeng, Pei Dong, Jing‐Jing Zhao, Yan Tang, Jingjing Li, Zhiling Zhang, Junyi He, Jieying Yang, Yue Huang, Ruiqing Peng, Qi‐Jing Wang, Jia‐Mei Gu, Jia He, Yong‐Qiang Li, Shi‐Ping Chen, Rongxing Huang, Zi‐Qi Zhou, Chaopin Yang, Yulong Han, Hao Chen, Heping Liu, Shangzhou Xia, Yang Wan, De‐Sheng Weng, Liming Xia, Fang‐Jian Zhou, Jian‐Chuan Xia
Publicado no Clinical & Translational Immunology (2021-01-01)